Rita Balice-Gordon, PhD
Muna Therapeutics
Dr. Balice-Gordon is the Chief Executive Officer of Muna Therapeutics. She is a Director on the Board of Collegium Pharmaceutical, and a Director on the Board of Capsida BioTherapeutics. Rita serves on the Scientific Advisory Boards of several biotech companies. Prior, Rita was the Global Head, Rare and Neurologic Diseases Research Therapeutic Area at Sanofi, Inc. for several years. Her main focus is the cellular and molecular interactions among neurons, their targets and the surrounding glia that mediate and modulate synapse formation and function during neural development.